The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: Neuropsychology and event-related potential measures

International Journal of Neuropsychopharmacology

Volumn 1, Issue 1, 1998, Pages 19-29

  Schall, Ulrich ^a,b   Catts, Stanley V ^a   Chaturvedi, Shail ^a   Liebert, Barbara ^a   Redenbach, Joanna ^a   Karayanidis, Frini ^a   Ward, Philip B ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Clozapine; Event related potentials; Frontal lobe functions; Neuropsychology; Schizophrenia

Indexed keywords

EID: 0003337478     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S146114579800100X     Document Type: Article

References (61)

1. Alho K, Woods DL, Algazi A, Knight RT, Näätänen R (1994). Lesions of frontal cortex diminish the auditory mismatch negativity in humans. Electroencephalography and Clinical Neurophysiology 91, 353-352.
2. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders. (3rd ed., rev.) Washington, DC: American Psychiatric Association Press.
3. Andreasen NC (1982). The Scale for the Assessment of Negative Symptoms. Iowa City, IA: University of Iowa.
4. Andreasen NC (1984). The Scale for the Assessment of Positive Symptoms. Iowa City, IA: University of Iowa.
5. Andreasen NC, Rezai K, Alliger R, Swayze VW, Flaum M, Kirchner P, Cohen G, O'Leary, DS (1992). Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Archives of General Psychiatry 49, 943-958.
6. Baker SC, Rogers RD, Owen AM, Frith CD, Dolan RJ, Frackowiak RSJ, Robbins TW (1996). Neural systems engaged by planning: a PET study of the Tower of London task. Neuropsychologia 34, 515-526.
7. Benton AL, Hamsher K (1978). Contributions to Neuropsychological Assessment. New York: Oxford University Press.
8. Boivin MJ, Giordani B, Berent S, Amato DA, Lehtinen S, Koeppe RA, Buchtel HA, Foster NL, Kuhl DE (1992). Verbal fluency and positron emission tomographic mapping of regional cerebral glucose metabolism. Cortex 28, 231-239.
9. Buchanan RW, Holstein C, Breier A (1994). The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biological Psychiatry 36, 717-725.
10. Carter CS, Robertson LC, Nordahl TE (1992). Abnormal processing of irrelevant information in chronic schizophrenia: Selective enhancement of Stroop facilitation. Psychiatry Research 41, 137-146.
11. Cleghorn JM, Garnett ES, Nahmias C, Brown, GM, Kaplan RD, Szechtman H, Szechtman B, Franco S, Dermer SW, Cook P (1990). Regional brain metabolism during auditory hallucinations in chronic schizophrenia. British Journal of Psychiatry 157, 562-570.
12. Cuesta MJ, Peralta V, Caro F, de Leon J (1995). Schizophrenic syndrome and Wisconsin Card Sorting test performance. Psychiatry Research 58, 45-51.
13. Davis KL, Kahn RS, Ko G, Davidson M (1990). Dopamine in schizophrenia: A review and reconceptualization. American Journal of Psychiatry 148, 1471-1486.
14. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Archives of General Psychiatry 49, 538-544.
15. Friedman D, Simpson GV (1994). ERP amplitude and scalp distribution to target and novel events: Effects of temporal order in young, middle-aged and older adults. Cognitive Brain Research 2, 49-63.
16. Frith CD (1992). The Cognitive Neuropsychology of Schizophrenia. Hillsdale: Lawrence Erlbaum.
17. Giard MH, Perrin F, Pernier J, Bouchet P (1990). Brain generators implicated in the processing of auditory stimulus deviance: A topographic event-related potential study. Psychophysiology 27, 627-640.
18. Goldberg TE, Greenberg RD, Griffin SJ, Gold JK, Kleinman JE, Pickar D, Schulz SC, Weinberger, DR (1993). The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. British Journal of Psychiatry 162, 43-48.
19. Goldberg TE, Weinberger, RD (1988). Probing prefrontal function in schizophrenia with neuropsychological paradigms. Schizophrenia Bulletin 14, 179-183.
20. Golden CJ (1976). Identification of brain disorders by the Stroop color and word test. Journal of Clinical Psychology 32, 654-658.
21. Gourovitch ML, Goldberg TW, Weinberger, DR (1996). Verbal fluency deficits in patients with schizophrenia: semantic fluency is differentially impaired as compared with phonologic fluency. Neuropsychology 10, 573-577.
22. Grace AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1-24.
23. Grillon C, Courchesne E, Ameli R, Geyer MA, Braff DL (1990). Increased distractibility in schizophrenic patients. Archives of General Psychiatry 47, 171-179.
24. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY (1993). Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biological Psychiatry 34, 707-712.
25. Himelhoch S, Taylor SF, Goldman RS, Tandon R (1996). Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes. Biological Psychiatry 39, 227-229.
26. Hoff AL, Faustmann WO, Wieneke M, Espinoza S, Costa M, Wolkowitz O, Csemansky JG (1996). The effect of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients. Neuropsychopharmacology 15, 361-369.
27. Kawasaki Y, Maeda Y, Suzuki M, Urata K, Higashima M, Kiba K, Yamaguchi N, Matsuda H, Hisada K. (1993). SPECT analysis of regional cerebral blood flow changes in patients with schizophrenia during the Wisconsin Card Sorting Test. Schizophrenia. Research 10, 109-116.
28. Kerwin RW (1994). The new atypical neuroleptics: a lack of extrapyramidal side-effects and new routes in schizophrenia research. British Journal of Psychiatry 164, 141-148.
29. Knight RT (1991). Evoked potential studies of attention capacity in human frontal lobe lesions. In: Levin HS, Eisenberg HM, Benton AL (Eds.) Frontal lobe function and dysfunction. New York: Oxford Press.
30. Kropotov JD, Näätänen R, Sevostianov AV, Alho K, Reinikainen K, Kropotova OV (1995). Mismatch negativity to auditory stimulus change recorded directly from the human temporal cortex. Psychophysiology 32, 418-422.
31. Lee AL, Thompson PA, Meltzer HY (1994). Effects of clozapine on cognitive function in schizophrenia. Journal of Clinical Psychiatry 55 (Supplement B): 82-87.
32. Lieberman JA, Safferman AZ (1992). Clinical profile of dozapine: adverse reactions and agranulocytosis. Psychiatric Quarterly. 63, 51-70.
33. Liddle PF, Morris DL (1991). Schizophrenic syndromes and frontal lobe performance. British Journal of Psychiatry 158, 340-345.
34. Lindenmayer JP, Grochowski S, Mabugat L (1994). Clozapine-effect on positive and negative symptoms: A six-month trial in treatment-refractory schizophrenics. Journal of Clinical Psychopharmacology 14, 201-205.
35. Lukoff D, Liberman RP, Nuechterlein KH (1986). Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin 12, 578-602.
36. Meltzer HY, Thompson PA, Lee MA, Ranjan R (1996). Neuropsychological deficits in schizophrenia. Relation to social function and effect of antipsychotic treatment. Neuropsychopharmacology 14 (Supplement): 27S-33S.
37. Mesulam M-M (1990). Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Annals of Neurology 28, 597-613.
38. Morris RG, Rushe T, Woodruffe PWR, Murray RM (1995). Problem solving in schizophrenia: a specific deficit in planning ability. Schizophrenia Research 14, 235-246.
39. Morris RG, Ashmed S, Syed GM, Toon BK (1993). Neural correlates of planning ability: Frontal lobe activation during Tower of London test. Neuropsychologia 31, 1367-1378.
40. Näätänen R (1992). Attention and Brain Function. Hillsdale: Lawrence Erlbaum.
41. Nagahama Y, Fukuyama H, Yamauchi H, Matsuzaki S, Konishi J, Shibasaki H, Kimura J (1996). Cerebral activation during performance of a card-sorting test. Brain 119, 1667-1675.
42. Nopoulus P, Flashman L, Flaum M, Amdt S, Andreasen N (1994). Stability of cognitive functioning early in the course of schizophrenia. Schizophrenia Research 14, 29-37.
43. Owen AM, Downes JJ, Sahakian BJ, Polky CE, Robbins TW (1990). Planning and working spatial memory following frontal lobe lesions in man. Neuropsychologia 28, 1021-1034.
44. Pardo JV, Pardo PJ, Janer KW, Raichle ME (1990). The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proceedings of the National Academy of Science USA 87, 256-259.
45. Park S, Holzman PS (1992). Schizophrenics show spatial working memory deficits. Archives of General Psychiatry 49, 975-982.
46. Perret E (1974). The left frontal lobe of man and the suppression of habitual responses in verbal categorical behavior. Neuropsychologia 12, 323-330.
47. Robbins TW (1990). The case of frontostriatal dysfunction in schizophrenia. Schizophrenia Bulletin 16, 391-402.
48. Sawaguchi T, Goldman-Rakic PS (1991). D1 dopamine receptors in the prefrontal cortex: Involvement in working memory. Science 251, 947-950.
49. Schall U, Catts SV, Chaturvedi S, Redenbach J, Karayanidis F, Ward PB (1995). The effect of clozapine therapy on psychometric and event-related potential (ERP) measures on cognitive dysfunction in schizophrenia. Schizophrenia Research 15 (1,2), 164.
50. Schall U, Schön A, Zerbin D, Eggers C, Oades RD (1996). Event-related potentials during an auditory discrimination with prepulse inhibition in patients with schizophrenia, obsessive-compulsive disorder and healthy subjects. International Journal of Neuroscience 84, 15-33.
51. Schall U, Ward PB (1996). 'Prepulse inhibition' facilitates a liberal response bias in an auditory discrimination task. NeuroReport 7: 652-656.
52. Shallice T (1982). Specific impairment of planning. Philosophical Transactions of the Royal Society of London B 298, 199-209.
53. Shallice T, Burgess PW, Frith CD (1991). Can the neuropsychological case-study approach be applied to schizophrenia? Psychological Medicine 21, 661-673.
54. Simms MGN, Patel JKM, Burke JG, Reveley MA, Dursun SM (1996). Effects of typical and atypical antipsychotic drug treatment on prefrontal-temporal-cortical network function in schizophrenia as assessed by 'COWA'. Proceedings of the BPS. British Journal of Clinical Pharmacology 42, 665P-666P.
55. Spitzer RL, Williams JBW, Gibbon M, First MB (1990). Structured Clinical Interview for DSM-III-R. American Psychiatric Association Press, Washington, DC.
56. Stuss DT, Benson DT (1984). The Frontal Lobes. New York : Raven Press.
57. Sullivan EV, Mathalon DH, Zipursky RD, Kersteen-Tucker Z, Knight RT, Pfefferbaum A (1993). Factors of the Wisconsin Card Sorting Test as measures of frontal-lobe function in schizophrenia and in chronic alcoholism. Psychiatry Research 46, 175-199.
58. Verdoux H, Magnin E, Bourgeois M (1995). Neuroleptic effects on neuropsychological test performance in schizophrenia. Schizophrenia Research 14, 133-139.
59. 2-Dopaminrezeptor-Blockade für die antipsychotische Wirkung von Neuroleptika. Eine PET-Studie an schizophrenen Patienten. In: Müller-Oerlinghausen B, Möller H-J, Rüther E (Hrsg.) Thioxanthene in der neuroleptischen Behandlung. (pp. 13-24) Berlin, Heidelberg: Springer-Verlag.
60. 1 receptors in prefrontal cortex. Nature 376, 572-575.
61. Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J (1992). Negative symtoms and hypofrontality in chronic schizophrenia. Archives of General Psychiatry 49, 959-965.